Katsuki Ohtani
Ebetsu, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Measurement of complement proteins may aid interpretation of pathophysiology in kidney transplant recipients with atypical hemolytic uremic syndrome.
Journal: CEN case reports
Published: December 25, 2025
Neutrophils predominate as IL1B-expressing cells in Schnitzler syndrome: Insights from the SCan study to evaluate the efficacy and safety of canakinumab in Japanese patients.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: February 10, 2025
Correction to: Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: A Japanese multicenter registry.
Journal: Clinical and experimental nephrology
Published: October 21, 2023
Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: A Japanese multicenter registry.
Journal: Clinical and experimental nephrology
Published: March 21, 2023
Antifungal activities of vineyard-habitat wild yeast for grape gray-mold disease and its effects on spontaneous winemaking.
Journal: Antonie van Leeuwenhoek
Published: November 12, 2022
Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders.
Journal: Frontiers in immunology
Published: November 05, 2022
Disseminated gonococcal infection in a Japanese man with complement 7 deficiency with compound heterozygous variants: A case report.
Journal: Medicine
Published: January 07, 2021
Complement-Related Proteins and Their Measurements: The Current Status of Clinical Investigation.
Journal: Nephron
Published: September 13, 2020
Purification, Quantification, and Functional Analysis of Collectins.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 20, 2020
Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding.
Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding.
Journal: Internal medicine (Tokyo, Japan)
Published: January 07, 2020
New Complement Therapeutics in Complement-Related Diseases
Journal: Brain and nerve = Shinkei kenkyu no shinpo
Published: June 07, 2019
Last Updated: 09/26/2026